Cancer-associated fibroblasts mediate resistance to neoadjuvant therapy in breast cancer

Clin Transl Med. 2024 Jul;14(7):e1779. doi: 10.1002/ctm2.1779.

Authors

Zihan Xia^{1

2}, Stephanie Vermeulen^{1

2}, Ujjwal Suwal³, Pekka Rappu³, Jyrki Heino³, Felix De Vuyst^{1

2}, Sandor Dedeyne^{1

2}, An Hendrix^{1

2}, Hannelore Denys^{2

4}, Olivier De Wever^{1

2}

Affiliations

¹ Department of Human Structure and Repair, Laboratory of Experimental Cancer Research, Ghent University, Ghent, Belgium.
² Cancer Research Institute Ghent, Ghent, Belgium.
³ Department of Life Technologies, University of Turku, Turku, Finland.
⁴ Department of Medical Oncology, Ghent University Hospital, Ghent, Belgium.

No abstract available

Publication types

Letter

MeSH terms

Breast Neoplasms* / drug therapy
Cancer-Associated Fibroblasts* / drug effects
Cancer-Associated Fibroblasts* / metabolism
Drug Resistance, Neoplasm* / drug effects
Female
Humans
Neoadjuvant Therapy* / methods

Grants and funding